Lv2
178 积分 2026-01-27 加入
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
4小时前
已完结
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
4小时前
已完结
Does needle size matter? Patient experience of luteinising hormone-releasing hormone analogue injection
13天前
已关闭
Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer
15天前
已完结
Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer
15天前
已关闭
Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer
15天前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
19天前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
22天前
已完结
皖公网安备34019202002308
